Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI
Clinical trial NCT06290817 · UNKNOWN
Trial details
- NCT number
- NCT06290817
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2025-03-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.